Floatz logo

Acyline

Androgen Deficiency

University of Washingtonprotein_peptidePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Androgen Deficiency cohort.

Asset / SponsorPhaseRating
Carboplatin
University of Washington
Phase 2BB
TESTOSTERONE UNDECYLATE
Royal College of Surgeons, Ireland
Phase 3BB
PREDNISONE TABLETS
SWOG Cancer Research Network
Phase 3BB
Abiraterone Acetate
SWOG Cancer Research Network
Phase 3BB
Docetaxel
SWOG Cancer Research Network
Phase 3BB

View all 36 →

Same molecule, other indications

Acyline is also rated in:

metabolic diseaseDormant
CCC
Indicative ·
52 / 100
View asset →
type 2 diabetes mellitusDormant
CCC
Indicative ·
50 / 100
View asset →
obesity disorderDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →